Intimation of Annual General Meeting and Record Date for payment of Final Dividend

Corporate Actions View source PDF Explain this filing

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹200.78

prior close

₹200.92

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.5%-1.4% vs market

Pharmaceuticals peers, median of 150sector-0.4%-0.5% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Smallcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

-0.2

15m

-1.0

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9+0.5-1.4-0.4-0.5

Next day

-3.1-0.2-2.9-1.7-1.4

-3.4-0.4-3.0-2.0-1.4

-4.5-2.3-2.2-3.9-0.6

-3.0-1.7-1.3-3.4+0.4

-3.1-0.9-2.2-3.3+0.1

+0.6+1.4-0.9-1.5+2.1

15d

+0.8+3.0-2.2-0.6+1.4

+6.9+4.5+2.4+0.8+6.1

-3.9-1.9-1.9-3.7-0.1

+2.3+1.0+1.3-2.4+4.7

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Piramal Pharma has scheduled its 5th Annual General Meeting (AGM) for Wednesday, 30th July 2025, to be held via video conferencing. The company has fixed Wednesday, 16th July 2025 as the Record Date to identify shareholders eligible to receive the Final Dividend for the financial year ended 31st March 2025. The dividend, as recommended by the Board of Directors, will be paid after approval at the AGM, subject to applicable tax deduction at source. The actual dividend amount per share is not disclosed in this filing.

Likely market impact

Investors holding shares of Piramal Pharma as of 16th July 2025 (record date) will be eligible to receive the Final Dividend once it is approved at the AGM on 30th July 2025. The stock may see mild positive sentiment around the record date as it typically trades ex-dividend shortly after.